Skip to main content
Toggle navigation
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Red Recording
Sig Meeting
Like
Tweet
Print
Qi Zhong, n/a
Pfizer (China) Research and Development Co Ltd, Shanghai, China
Poster(s):
(T 22) Rimegepant for the Preventive Treatment of Migraine: A Phase 3, Randomized, Double-blind, Placebo-controlled Study in Adults from China
